CN105124347A - Moringa oleifera blood-glucose-reducing composition and preparation method thereof - Google Patents

Moringa oleifera blood-glucose-reducing composition and preparation method thereof Download PDF

Info

Publication number
CN105124347A
CN105124347A CN201510439662.3A CN201510439662A CN105124347A CN 105124347 A CN105124347 A CN 105124347A CN 201510439662 A CN201510439662 A CN 201510439662A CN 105124347 A CN105124347 A CN 105124347A
Authority
CN
China
Prior art keywords
moringa
blood
composition
hypoglycemic
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510439662.3A
Other languages
Chinese (zh)
Inventor
张德旺
蒋盛军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hainan Mu La Da Biotechnology Co Ltd
Original Assignee
Hainan Mu La Da Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hainan Mu La Da Biotechnology Co Ltd filed Critical Hainan Mu La Da Biotechnology Co Ltd
Priority to CN201510439662.3A priority Critical patent/CN105124347A/en
Publication of CN105124347A publication Critical patent/CN105124347A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The invention relates to the technical field of health-caring foods and particularly discloses a moringa oleifera blood-glucose-reducing composition and a preparation method thereof. The composition is prepared from following raw materials, by weight, 20-80% of leaves of moringa oleifera, 1-20% of schisandra chinensis, 1-20% of fructus lycii, 1-20% of Chinese yam, 1-20% of poria cocos, and 1-20% of fructo-oligosaccharide. The leaves of moringa oleifera, as a monarch drug, is used for promoting blood glucose metabolism and reducing blood glucose concentration in body; the schisandra chinensis, as a minister drug, is used for enhancing work in five viscera; the fructus lycii, as an assistant drug, is used for promoting lifting of kidney to dilute blood glucose; the Chinese yam and the poria cocos, as guide drugs, is used for promoting normal work of digestion system and meridian system in body, thereby ensuring absorption and digestion of the medicine; and the fructo-oligosaccharide, as a guide drug, is used for promoting absorption of blood glucose reducing active components in body. By means of compatibility of the raw material drugs, the composition is strong in blood-glucose-reducing effect. The preparation method is simple in operation and is suitable for being industrially popularized.

Description

A kind of Moringa hypoglycemic composition and preparation method thereof
Technical field
The present invention relates to technical field of health care food, be specifically related to a kind of Moringa hypoglycemic composition and preparation method thereof.
Background technology
Moringa, Capparales Moringaceae, originate in India, be also called drumstick tree, it is perennial tropical deciduous tree, about there are 14 kinds in the whole world, and kind comparatively normal edible at present has following three kinds: India's tradition Moringa, India's improvement kind of Moringa (the improvement kind of T.N. agriculture university of India, early raw and tool high pod yield) and African Moringa (former originates in the neighbouring and Ethiopia west and south of Kenya's Turkana Lake).Blade and the fruit pod of Moringa contain several mineral materials, vitamin, 20 seed amino acids, 46 kinds of antioxygen elements, 36 kinds of naturally anti-scorching bodies and mineral matters.Research shows, the vitamin e content in the fresh blade of 100 grams of India's tradition Moringas is about 9 milligrams, and in dry blade, vitamin e content is about 16.2 milligrams.The vitamin C contained in the Moringa of every 100 grams is 7 times of oranges and tangerines, and iron is 3 times of spinach, and vitamin A is 4 times of carrot, and calcareous is 4 times of milk, and potassium is 3 times of banana, and protein is 2 times of Yoghourt.According to calculating, if the leaf of Moringa dry powder of three soupspoons (about 25 grams) just containing needed for child every day 270% vitamin A, the protein of 42%, the calcium of 125%, the iron of 70% and the vitamin C of 22%.For the women in conceived and lactation, Moringa blade and beanpod also can help me and fetus or baby to remain healthy, provide a large amount of ironys, protein, copper, sulphur and vitamin B.
Because Moringa contains abundant nutritional labeling; the function of augment nutritional, Dietotherapy health is had as raw-food material; can activating cell develop immunitypty; contribute to excreting insulin and regulate blood sugar, anti-oxidant, Green Tea Extract, elimination human body active oxygen, have abundant health care's effect effectively; long-term taking for antihypertensive, high fat of blood falls, reducing hyperglycaemia has positive effect; prevention and control of cancer tumour can also be prevented, develop immunitypty cardioprotection, prophylactic treatment diabetes.And due to the above-mentioned health-care efficacy of Moringa, be that the health food of raw material emerges in large numbers gradually with Moringa, as Chinese patent CN104432082A discloses a kind of Moringa, blueberry mixed health lozenge, make for raw material with leaf of Moringa Ultramicro-powder, blueberry Ultramicro-powder, flavor enhancement, bonding agent, lubricant, there is anti-oxidant, remitting vision fatigue, enhancing cardiac function and body immunity, prevention diabetes, hypertension health care, although the Moringaceae tablet of the disclosure has multiple-effect health care, but the specific aim lacked for effect of lowering blood sugar, and blood sugar decreasing effect is not remarkable.Further, existing many Moringa health products form according to mouthfeel and nutrition arrangement mostly, not obvious for this effect hypoglycemic.In a word, in current Moringa health product, lack the specific aim for Hyperglycemic health care effect and selectivity, thus well health care and preventive effect can not be played to diabetic.
Summary of the invention
In order to overcome the defect of prior art, an object of the present invention is to provide a kind of Moringa hypoglycemic composition, has significant effect of lowering blood sugar.
Meanwhile, the present invention is also the preparation method providing a kind of Moringa hypoglycemic composition.
In order to realize above object, the technical solution adopted in the present invention is as follows:
A kind of Moringa hypoglycemic composition, is made up of the raw material of following weight percentage: leaf of Moringa 20 ~ 80%, the fruit of Chinese magnoliavine 1 ~ 20%, matrimony vine 1 ~ 20%, mountain, Huaihe River 1 ~ 20%, Poria cocos 1 ~ 20%, FOS 1 ~ 20%.
Preferably, leaf of Moringa is Moringa young stem and leaf.
Each raw material abbreviated functional description:
Leaf of Moringa is natural green food, and the complete nutrients matter containing needed by human body, can replace B B-complex, calcium tablet, cod-liver oil etc., has good effect especially to hypertension, high fat of blood, diabetes, gout etc.Leaf of Moringa itself has multiple health-care effect, but lacks specific aim, so single hypoglycemic activity DeGrain.
The fruit of Chinese magnoliavine (profound and, meeting and, five plums) point fructus schisandrae and kadsura longepedunculata, fructus schisandrae matter is more excellent than kadsura longepedunculata.Fruit of Chinese magnoliavine happiness subacidity fertile soil, needs enough moisture and nutrition growth period; Be distributed in the ground such as Heilungkiang, Jilin, Liaoning, the Inner Mongol, Hebei; Have astringe the lung, nourshing kidney, promote the production of body fluid, receive sweat, puckery essence effect, there is the effect regulating human body function of five internal organs.
Matrimony vine, the flat taste of property is sweet, enter liver, kidney channel, there is effect of replenishing the vital essence and the blood, nourishing liver and kidney, benefiting shrewd head, be usually used in treating the disease such as soreness and weakness of waist and knees, dizziness, tinnitus, seminal emission suffered from a deficiency of the kidney caused by damage, asthenia of essence and blood of liver, to kidney deficiency and liver, essence and blood can not on disease curative effects such as, hypopsia dim-sighted in the eyes caused by order of helping especially good.Modern pharmacological research shows, matrimony vine contains the composition such as carrotene, betaine, vitamin A, vitamin B1, vitamin B2, vitamin C and calcium, phosphorus, iron, there is the effect strengthening leukocyte activity, suppress fat deposition, promotion liver cell new life in liver cell, evident in efficacy to chronic hepatitis, central retinitis, optic atrophy etc., also can hypotensive, hypoglycemic, reducing blood lipid.
Huai Shan, as health food, at least has more than 2,000 year in China, becomes book in the Eastern Han Dynasty, and Huai Shan is classified as top grade by the existing pharmacy monograph Shennong's Herbal the earliest of China, but mountain, Huaihe River at this moment may be wild, does not also enter the cultivation stage.To " mountain occupies and wants art " that the Tang Dynasty " when four bun will " scholar king's Japanese of leading the way is shown, done comparatively detailed record to Huai Shan cultivation, from then on, Huai Shan progressively becomes one of vegetables.Import of Chinese medical books thinks Huai Shan " in main wound qi-restoratives, except fever and chills perverse trend, tonifying middle-Jiao and Qi power, longue meat, take normal hearing and eyesight for a long time ".Many allusion doctor mats have all done very high evaluation to Huai Shan.Among the people, Huai Shan is the confessed excellent tonic products of people, it contains the compositions such as protein, carbohydrate, vitamin, fat, choline, amylase, mucus juice, also containing the indispensable inorganic salts of human body and trace elements such as iodine, calcium, iron, phosphorus, and more than Ipomoea batatas one times of the content of phosphorus, more than potato two times.Scientific analysis, the maximum feature of mountain, Huaihe River nutrition is containing a large amount of mucoproteins, and mucoprotein is a kind of mixture of proteinpolysaccharide, has special health-care effect to human body, has and falls hypoglycemic effect, can be used for treating diabetes; And can prevent the sedimentation of fat on cardiovascular, keep blood vessel elasticity, stop atherosclerotic to occur too early; Can subcutaneous fat be reduced, there is antiobesity action; The atrophy of connective tissue can be prevented, therefore the generation of the collagen disease such as rheumatoid arthritis, chorionitis can be prevented.Many nourishing prescriptions, the Chinese medicine such as loose in Liuwei Dihuang Wan, Chinese holly Ju Dihuang ball, guipi decoction, the ginseng ridge bighead atractylodes rhizome all contains Huai Shan.What the Ming Dynasty was famous lengthen one's life food--eight-treasure cake grinds as smalls by 8 taste Chinese medicines such as Huai Shan, hawthorn, Fructus Hordei Germinatus, and with the cake that ground rice is made, and is used for the treatment of weakness of the spleen and the stomach, the few abdominal distension of food of child old man, the disease had loose bowels in lean and haggard, loose stool, Be very effective.
Poria cocos, is commonly called as Yun Ling, Song Ling, Fu spirit, and for colonizing in the fungi plant on pine roots, shape is as sweet potato, and crust pitchy, the inside is white or pink.Modern pharmacological research shows: the active ingredient pachymaran in Poria cocos has obvious antitumor action; Simultaneously Poria cocos also has enhanced machine body immunity function, has diuresis, to increase in urinating the electrolytical discharges such as potassium, sodium, chlorine; There is calmness and protection liver, suppress the generation of ulcer, there is the effects such as hypoglycemic, anti-radiation.Poria cocos is also used as the raw material of the crisp and tuckahoe wine of cake, Poria cocos as the food of integration of drinking and medicinal herbs, and some countries are using the raw material of Poria cocos as naval's common drug and invigorant.In the larger area of temperature and place, Poria cocos can be used as important dietotherapy kind, often ediblely can invigorating the spleen dry, aid digestion, strong physique.
FOS is a kind of water-soluble dietary fiber, and long-term taking can reduce serum cholesterol, improves lipid-metabolism, and directly can not be digested and assimilated by human body, can only be absorbed by enteric bacteria, is a kind of good sweetener concerning diabetic.Clinical test results shows, and FOS has following physiological function: have regulating intestinal canal flora, and the effect of propagation Bifidobacterium, Bifidobacterium breeds 10 ~ 100 times under the effect of FOS, has effect of bidirectional modulation.After human body takes in FOS, in body, profitable strain bifidobacteria can suppress intrinsic putrefactivebacteria in external source pathogenic bacteria and intestines as growth and breedings such as salmonellas, to reduce growth and the accumulation of corrupt substance in intestines, promote intestines peristalsis, prevent constipation and diarrhoea.FOS is generated Pfansteihl by bacterial fermentation in large intestine, can the mineral matter such as dissolving calcium, magnesium, iron, promotes that human body is to the absorption of mineral matter.Meanwhile, FOS is a kind of well binding agent, thus avoids the binding agent of the toxic side effect adding other.
Moringa hypoglycemic composition of the present invention, with leaf of Moringa, the fruit of Chinese magnoliavine, matrimony vine, Huai Shan, Poria cocos and FOS for raw material is prepared from, wherein leaf of Moringa has the active component directly promoting blood sugar reduction, the fruit of Chinese magnoliavine, matrimony vine, Huai Shan, Poria cocos and FOS are by the function of adjustment human body other organs, indirectly-acting reduces blood sugar for human body, thus strengthens the hypoglycemic effect of Moringa.The present invention works in coordination with the theory of making up a prescription of compatibility according to traditional Chinese medical science monarch, by adjusting the consumption of each raw material, makes mutually to act synergistically between each raw material.Leaf of Moringa is monarch drug in a prescription, promotes body metabolism, thus promotes metabolism of blood glucose, reduce human blood glucose concentration by materials such as excess fats in removing human vas and tissue; The fruit of Chinese magnoliavine is ministerial drug, strengthens the operation of the five internal organs of human body, allows the operation of human five internal organs more coordinate; Matrimony vine is adjutant, kidney tonifying, promotes the lifting of kidney water, thus the sugared concentration in dilute blood; Huai Shan and Poria cocos make medicine, and promote the normal operation of digestion and channel system, guarantee the absorption of medicine, digestion, Poria cocos also has the function of mind-tranquilizing brain-strengthening.FOS makes medicine, and it can adjust the Tiny ecosystem of the gi system of human body, promotes that human body is to the absorption of hypoglycemic active ingredient.By the comprehensive function of above-mentioned each bulk drug, the Moringa hypoglycemic composition prepared is made to have very strong effect of lowering blood sugar, can some special hypoglycemic drugs of Some substitute, treatment and the prevention of diabetes can be assisted, reduce owing to taking the toxic and side effect or complication that diabetes chemical synthesis hypoglycemic drug causes.
Preferably, above-mentioned each raw material is Powdered.
Above-mentioned each raw material is Powdered.
The formulation of above-mentioned Moringa hypoglycemic composition is tablet.
Above-mentioned Moringa hypoglycemic composition can be also other medically acceptable formulations, as granule, capsule, pulvis, oral liquid etc.And adopt the customary preparation methods of pharmaceutical formulating art can obtain the Moringa hypoglycemic composition of other formulations.
The preparation method of above-mentioned Moringa hypoglycemic composition, comprises after each raw material mixing and stirring, compressing tablet, dry, obtains described Moringa hypoglycemic composition.
Preferably, also comprise each raw material is shattered powdered after mixing and stirring again.
Preferably, described drying is for being dried to water content lower than 10%.
The preparation method of Moringa hypoglycemic composition of the present invention, adopts mode shaping for direct tablet compressing after each raw material mixing, easy and simple to handle, is easy to realize, is convenient to industrial application.
Detailed description of the invention
Below by specific embodiment, technical scheme of the present invention is described in detail.
In following embodiment, Moringa hypoglycemic composition is tablet, but this formulation does not form any limitation of the invention, and the change of formulation does not affect the health-care effect of Moringa hypoglycemic composition of the present invention.
Embodiment 1
The present embodiment Moringa hypoglycemic composition, its formulation is tablet, is made up of the raw material of following weight percentage: leaf of Moringa 45%, the fruit of Chinese magnoliavine 10%, matrimony vine 10%, mountain, Huaihe River 5%, Poria cocos 10%, FOS 20%.
The preparation method of the present embodiment Moringa hypoglycemic composition, concrete operation step is:
1) getting each raw meal is broken into Powdered;
2) by after pulverous each raw material mixing and stirring, compression molding, is dried to water content lower than 10%, obtains described Moringa hypoglycemic composition.
The hypoglycemic tablet of Moringa prepared by the present embodiment, the weight of average every sheet is 0.7g.
Embodiment 2
The present embodiment Moringa hypoglycemic composition, its formulation is tablet, is made up of the raw material of following weight percentage: leaf of Moringa 20%, the fruit of Chinese magnoliavine 20%, matrimony vine 20%, mountain, Huaihe River 10%, Poria cocos 20%, FOS 10%.
The preparation method of the present embodiment Moringa hypoglycemic composition, concrete operation step is:
1) getting each raw meal is broken into Powdered;
2) by after pulverous each raw material mixing and stirring, compression molding, is dried to water content lower than 10%, obtains described Moringa hypoglycemic composition.
The hypoglycemic tablet of Moringa prepared by the present embodiment, the weight of average every sheet is 0.7g.
Embodiment 3
The present embodiment Moringa hypoglycemic composition, its formulation is tablet, is made up of the raw material of following weight percentage: leaf of Moringa 60%, the fruit of Chinese magnoliavine 15%, matrimony vine 15%, mountain, Huaihe River 1%, Poria cocos 8%, FOS 1%.
The preparation method of the present embodiment Moringa hypoglycemic composition, concrete operation step is:
1) getting each raw meal is broken into Powdered;
2) by after pulverous each raw material mixing and stirring, compression molding, is dried to water content lower than 10%, obtains described Moringa hypoglycemic composition.
The hypoglycemic tablet of Moringa prepared by the present embodiment, the weight of average every sheet is 0.7g.
Embodiment 4
The present embodiment Moringa hypoglycemic composition, its formulation is tablet, is made up of the raw material of following weight percentage: leaf of Moringa 80%, the fruit of Chinese magnoliavine 1%, matrimony vine 1%, mountain, Huaihe River 7%, Poria cocos 1%, FOS 10%.
The preparation method of the present embodiment Moringa hypoglycemic composition, concrete operation step is:
1) getting each raw meal is broken into Powdered;
2) by after pulverous each raw material mixing and stirring, compression molding, is dried to water content lower than 10%, obtains described Moringa hypoglycemic composition.
The hypoglycemic tablet of Moringa prepared by the present embodiment, the weight of average every sheet is 0.7g.
Comparative example
This comparative example Moringa hypoglycemic composition is made up of the raw material of following weight percentage: leaf of Moringa 90%, xylitol 5%, FOS 5%.The method same according to embodiment 1 is prepared into tablet.
Test example 1
Test method: by 40 fasting plasma glucose concentration between 7.0 ~ 11.0mmol/L, the sub-health population suffering from slight diabetes is divided into two groups at random; Wherein one group of Moringa hypoglycemic composition taken the embodiment of the present invention 1 and prepare; Other one group of Moringa hypoglycemic composition taken comparative example and prepare; Observe the blood sugar concentration often organizing patient and reduce situation.
Usage and dosage: everyone is each serving with three, and one day secondary, takes two months continuously.
Result of the test: the patient's fasting plasma glucose concentration taking Moringa blood pressure reducing composition prepared by the embodiment of the present invention 1 on average reduces 1.46mmol/L; The patient's fasting plasma glucose concentration taking Moringa hypoglycemic composition prepared by comparative example on average reduces 0.37mmol/L.
From above-mentioned result of the test, the blood sugar decreasing effect of Moringa hypoglycemic composition prepared by the embodiment of the present invention 1 is obviously better than Moringa hypoglycemic composition prepared by comparative example.Show that Moringa hypoglycemic composition prepared by the embodiment of the present invention 1 has hypoglycemic and adjuvant treatment effect preferably to mild diabetes patient.Test example 2
Test method: by 40 fasting plasma glucose concentration between 12 ~ 20.0mmol/L, suffers from and is divided into two groups at random compared with the crowd of severe diabetes mellitus; Wherein one group of Moringa hypoglycemic composition taken the embodiment of the present invention 1 and prepare; Other one group of Moringa hypoglycemic composition taken comparative example and prepare; Observe the blood sugar concentration often organizing patient and reduce situation.
Usage and dosage: everyone is each serving with three, and one day secondary, takes two months continuously.
Result of the test: the patient's fasting plasma glucose concentration taking Moringa blood pressure reducing composition prepared by the embodiment of the present invention 1 on average reduces 1.78mmol/L; The patient's fasting plasma glucose concentration taking Moringa hypoglycemic composition prepared by comparative example on average reduces 0.53mmol/L.
From above-mentioned result of the test, the blood sugar decreasing effect of Moringa hypoglycemic composition prepared by the embodiment of the present invention 1 is obviously better than Moringa hypoglycemic composition prepared by comparative example.Show that Moringa hypoglycemic composition prepared by the embodiment of the present invention 1 has hypoglycemic and adjuvant treatment effect preferably to compared with severe diabetes mellitus patient.
The blood sugar decreasing effect of Moringa blood pressure reducing composition prepared by embodiment 2 ~ 4 is suitable with embodiment 1.
The result of the test of above-mentioned test example 1 and test example 2 shows, the leaf of Moringa in Moringa hypoglycemic composition of the present invention and the fruit of Chinese magnoliavine, matrimony vine, Huai Shan, there is synergistic function between Poria cocos and FOS, strengthens the blood sugar decreasing effect of leaf of Moringa.Meanwhile, Moringa hypoglycemic composition of the present invention all has good blood sugar decreasing effect to diabetic in various degree, may be used for taking good care of the auxiliary of diabetes.

Claims (6)

1. a Moringa hypoglycemic composition, is characterized in that, is made up of the raw material of following weight percentage: leaf of Moringa 20 ~ 80%, the fruit of Chinese magnoliavine 1 ~ 20%, matrimony vine 1 ~ 20%, mountain, Huaihe River 1 ~ 20%, Poria cocos 1 ~ 20%, FOS 1 ~ 20%.
2. Moringa hypoglycemic composition as claimed in claim 1, it is characterized in that, each raw material is Powdered.
3. Moringa hypoglycemic composition as claimed in claim 1, it is characterized in that, its formulation is tablet.
4. a preparation method for Moringa hypoglycemic composition as claimed in claim 3, is characterized in that, comprises after being mixed by each raw material, compressing tablet, dry, obtains described Moringa hypoglycemic composition.
5. the preparation method of Moringa hypoglycemic composition as claimed in claim 4, is characterized in that, also comprise each raw meal is broken into Powdered after mix again.
6. the preparation method of Moringa hypoglycemic composition as claimed in claim 4, it is characterized in that, described drying is for being dried to water content lower than 10%.
CN201510439662.3A 2015-07-24 2015-07-24 Moringa oleifera blood-glucose-reducing composition and preparation method thereof Pending CN105124347A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510439662.3A CN105124347A (en) 2015-07-24 2015-07-24 Moringa oleifera blood-glucose-reducing composition and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510439662.3A CN105124347A (en) 2015-07-24 2015-07-24 Moringa oleifera blood-glucose-reducing composition and preparation method thereof

Publications (1)

Publication Number Publication Date
CN105124347A true CN105124347A (en) 2015-12-09

Family

ID=54710227

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510439662.3A Pending CN105124347A (en) 2015-07-24 2015-07-24 Moringa oleifera blood-glucose-reducing composition and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105124347A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105434978A (en) * 2015-12-14 2016-03-30 昭通市益雄药业有限公司 Polygonatum rhizome tea
CN105833109A (en) * 2016-06-15 2016-08-10 谢晓亮 Moringa oleifera-containing composition for treating hyperglycemia and hyperlipidemia and preparation method and application thereof
CN106266429A (en) * 2016-08-23 2017-01-04 李西平 A kind of compositions being applicable to diabetes patient and diet therapy soup thereof and preparation method
CN107149082A (en) * 2016-03-02 2017-09-12 上海宣泰生物科技有限公司 A kind of composition for the high resistant starch content ground rice for preventing and treating diabetes
CN107259003A (en) * 2017-05-12 2017-10-20 安徽爱华特生物科技有限公司 A kind of lycium ruthenicum Moringa ginseng health protection tea and its application
CN113499352A (en) * 2021-07-06 2021-10-15 中南大学湘雅医院 Application of moringa seed extract in preparation of medicine for preventing and/or treating kidney diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104544124A (en) * 2015-01-15 2015-04-29 云南众爱生物科技有限公司 Chia seed-containing dietary fibre meal replacement
CN104622922A (en) * 2015-02-10 2015-05-20 湖州健泰食品有限公司 Horseradish tree leaf tablet and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104544124A (en) * 2015-01-15 2015-04-29 云南众爱生物科技有限公司 Chia seed-containing dietary fibre meal replacement
CN104622922A (en) * 2015-02-10 2015-05-20 湖州健泰食品有限公司 Horseradish tree leaf tablet and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
季昌群等: "《血糖控制应注意的细节》", 31 August 2012, 金盾出版社 *
王辉等: "《糖尿病患者医食住行》", 31 October 2013, 金盾出版社 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105434978A (en) * 2015-12-14 2016-03-30 昭通市益雄药业有限公司 Polygonatum rhizome tea
CN107149082A (en) * 2016-03-02 2017-09-12 上海宣泰生物科技有限公司 A kind of composition for the high resistant starch content ground rice for preventing and treating diabetes
CN105833109A (en) * 2016-06-15 2016-08-10 谢晓亮 Moringa oleifera-containing composition for treating hyperglycemia and hyperlipidemia and preparation method and application thereof
CN105833109B (en) * 2016-06-15 2020-01-17 河北省农林科学院经济作物研究所 Moringa oleifera-containing composition for treating hyperglycemia and hyperlipidemia and preparation method and application thereof
CN106266429A (en) * 2016-08-23 2017-01-04 李西平 A kind of compositions being applicable to diabetes patient and diet therapy soup thereof and preparation method
CN107259003A (en) * 2017-05-12 2017-10-20 安徽爱华特生物科技有限公司 A kind of lycium ruthenicum Moringa ginseng health protection tea and its application
CN113499352A (en) * 2021-07-06 2021-10-15 中南大学湘雅医院 Application of moringa seed extract in preparation of medicine for preventing and/or treating kidney diseases

Similar Documents

Publication Publication Date Title
CN103054113B (en) Composite fruit-vegetable juice beverage with blood sugar decreasing effect
CN105124347A (en) Moringa oleifera blood-glucose-reducing composition and preparation method thereof
CN104026446A (en) Nutritional meal replacement powder suitable for crowd with hyperglycemia and preparation method thereof
CN102919450B (en) Cereal leaching solution herbal tea and method for preparing same
CN103191332A (en) Composition and health-care product with stomach-invigorating and digestion-promoting functions
CN101579120A (en) Nutritional food with weight-losing function and preparation method thereof
CN102048225B (en) Red-date health protection beverage capable of improving growing development
CN106418545A (en) Functional food with balanced nutrients
CN105360494A (en) Decompression health care sweet osmanthus tea and manufacturing method thereof
KR101611954B1 (en) A process for the preparation of fermented minerals pills for improving intestine function and fermented minerals pills prepared therefrom
CN106418501A (en) Healthcare food with weight reducing function
KR101578070B1 (en) Health supplementing food for enhancing hair restoration, alleviating and improving hair loss, adjusting blood sugar, alleviating and improving gastrointestinal disorders
CN104095272A (en) Maca health care drink
CN104957474A (en) Moringa oleifera composition for reducing blood pressure and preparation method of moringa oleifera composition
CN106387900A (en) Composition for regulating blood lipid, blood pressure and blood sugar, as well as application thereof
CN109043553A (en) A kind of Special food and preparation method thereof that patients with gestational diabetes is edible
CN102511876B (en) Hawthorn red jujube thick syrup and production process thereof
CN105166620A (en) Horseradish tree composition capable of reducing blood lipid and preparation method of horseradish tree composition
CN105341704A (en) Brown sugar red bean paste
CN105285284A (en) Grifola frondosa domestic fungus pressed candy and making method thereof
CN104938900A (en) Moringa hangover-alleviating composition and preparation method thereof
CN101797049B (en) Nutrient eight-treasure soup formula and preparation process thereof
CN104839699A (en) Heart disease non-total nutrient formula food
CN103181557A (en) Nutritious food with slimming function and preparation method thereof
CN104304487A (en) Health milk with efficacy of decreasing blood sugar and preparation method of health milk

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20151209

RJ01 Rejection of invention patent application after publication